Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05099549
Title Safety, Tolerability, and Anti-Tumor Activity of AFM24 in Combination With SNK01 in Subjects With Advanced/Metastatic EGFR-Expressing Cancers
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors NKGen Biotech, Inc.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
USC/Norris Comprehensive Cancer Center Los Angeles California 90033 United States Details
Sarcoma Oncology Center Santa Monica California 90403 United States Details
University of Chicago Chicago Illinois 60611 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field